前列腺癌的功能性与靶向淋巴结成像:现状与未来挑战
综述讨论前列腺癌区域淋巴结转移的分期难题:传统CT和MR仅凭淋巴结大小判断,敏感度和特异度不足;扩散加权MR、氧化铁颗粒MR淋巴造影和靶向PET等新技术正在发展中,似乎可改善淋巴结分期,但尚未达到替代扩大盆腔淋巴结清扫的程度。
要点
- 传统CT和MR依赖淋巴结大小标准,对前列腺癌淋巴结分期敏感度和特异度不足。
- 扩散加权MR、氧化铁颗粒MR淋巴造影和靶向PET等新技术似乎可改善淋巴结分期。
- 影像学淋巴结分期尚未达到替代扩大盆腔淋巴结清扫(ePLND)的程度。
核心结论
- 功能性与靶向淋巴结成像新技术似乎可改善前列腺癌淋巴结分期,但尚未达到替代扩大盆腔淋巴结清扫的程度。
研究设计与样本
- 综述,讨论前列腺癌功能性与靶向淋巴结成像技术的优势与局限性。
关键影像表现/征象
- 传统CT和MR依赖淋巴结大小标准,对淋巴结转移的判定不敏感且不特异。
- 功能MR成像采用扩散加权MR成像,靶向PET成像和氧化铁颗粒MR淋巴造影正在发展中。
临床应用与阅片要点
- 传统CT和MR的淋巴结大小标准不可靠,阅片时需认识其不敏感、不特异的局限。
- 功能性与靶向淋巴结成像新技术可用于改善分期,但原文未据此给出替代ePLND的推荐。
局限性
- 影像学淋巴结分期尚未达到替代扩大盆腔淋巴结清扫的程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Patients with prostate cancer who have regional lymph node (LN) metastases face an increased risk of death from disease and are therefore treated aggressively. Surgical LN dissection is the established method of staging regional nodes; however, this invasive technique carries substantial morbidities and a noninvasive imaging method is needed to reduce or eliminate the need for extended pelvic LN dissections (ePLND). Conventional computed tomography and magnetic resonance (MR) imaging have proven insensitive and nonspecific because both use nodal size criteria, which is notoriously inaccurate. Novel imaging techniques such as functional MR imaging by using diffusion-weighted MR imaging, MR lymphography with iron oxide particles, and targeted positron emission tomography imaging are currently under development and appear to improve LN staging of prostate cancer. Although progress is being made in staging nodes with imaging, it has not reached the point of replacing ePLND. In this review, the strengths and limitations of these new functional and targeted LN imaging techniques for prostate cancer are discussed. © RSNA, 2017.
引用
- Thoeny HC, Barbieri S, Froehlich JM, et al. Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges. Radiology. 2017. PMID: 29155624. doi:10.1148/radiol.2017161517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。